Japan-based cell therapy company Innovacell is planning to end a drought of biotech IPOs on the Tokyo stock exchange next week, the business’ CEO has confirmed.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Japan-based cell therapy company Innovacell is planning to end a drought of biotech IPOs on the Tokyo stock exchange next week, the business’ CEO has confirmed.